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Abstract
This paper presents the results of an assessment of the provision of emergency 
contraceptives (EC) in private pharmacies in Nairobi, Kenya. Trained female mys-
tery clients (MCs) made a total of 103 visits to 20 randomly selected pharmacies 
and presented accounts of their experiences. The results show that: 1) some pro-
viders insist on doctors’ prescriptions before they can dispense EC; 2) there are 
variations among providers on the recommended dosage and possible side-effects 
of EC pills; 3) MCs presenting as inexperienced clients were significantly more 
likely to be given additional information on EC than the experienced ones; 4) 
there was no significant difference in the provision of additional reproductive 
health (RH) information/services by the scenario presented. This suggests the 
need for: 1) provider training and/or updates on EC to enhance their capacity to 
offer additional RH information/services; 2) sensitizing EC clients on the impor-
tance of obtaining additional RH information/services from providers.
Keywords: Emergency contraceptives, Kenya, provision, private 
pharmacies, mystery clients
Résume
Ce document présente les résultats d’une évaluation sur l’offre des méthodes de 
contraception d’urgence (CU) dans les pharmacies privées de Nairobi, au Kenya. 
Les clients « mystères » formés avaient fait au total 103 visites au niveau de 20 
pharmacies choisies au hasard et ont pu partager leurs expériences. Les résultats 
ont montré que: 1) les prestataires de service exige une prescription médicale 
pour l’offre d’une CU; 2) les avis des prestataires de service différent quant à la 
posologie et aux effets secondaires éventuels liés à l’utilisation des pilules de CU; 
3) les clients « mystères » présentés comme étant des clients inexpérimentés 
étaient plus susceptibles de recevoir des informations complémentaires sur la CU 
que celles qui en  avaient l’expérience; 4) selon le scénario présenté, il n’y avait 
pas de différence majeure sur l’offre de l’information/services complémentaires 
liés à la santé de la reproduction. Cela implique le besoin de: 1) former et faire 
des mises à jour sur la CU pour renforcer les capacités des prestataires de serv-
ices dans l’offre d’informations /services complémentaires; 2) sensibiliser les cli-
ents sur l’importance d’obtenir de la part des prestataires de services des 
informations complémentaires sur la CU.42
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Over the past decade, emergency con-
traceptives (EC) have become increas-
ingly available across Africa 
(Schiappacasse and Diaz, 2006).2
Although more government clinics than 
ever before are providing EC, in many 
countries private sector pharmacies 
remain the main channel through which 
clients obtain EC pills (Programme for 
Appropriate Technology in Health 
(PATH), 2004; Blanchard et al., 2005; 
United Kingdom Office of National Sta-
tistics, 2005; Moreau et al., 2006; Schi-
appacasse and Diaz, 2006). This is 
mainly because of the conveniences 
such outlets offer, namely, affordability, 
quick service delivery, and confidential-
ity. Owing to client preference, private 
pharmacies can play an important role 
in providing EC and possibly other 
reproductive health (RH) information 
and services to clients (Wells et al., 
1998; PATH, 2004). To begin with, the 
need for EC because of regular unpro-
tected sex or method failure suggests 
the need for a new or more reliable 
method of family planning (FP). Moreo-
ver, clients who seek EC may also have 
exposed themselves to the risk of sexu-
ally transmitted infections (STIs), 
including HIV/AIDS in high prevalence 
settings, and are therefore candidates 
for voluntary counselling and testing 
(VCT) services. Thus, a client’s decision 
to use EC can be seen as marking the 
beginning of a new set of RH needs.
It is, however, not clear whether 
private sector pharmacy providers have 
the capacity to offer the additional 
information and services to EC clients. 
First, from a public health perspective, 
private pharmacies lack the incentives 
to take up important steps in providing 
services to EC clients such as counsel-
ling or referrals for on-going contracep-
tion and STIs/HIV prevention, a 
concept referred to as bridging. This 
could be attributed to two factors, 
namely, the nature of training for phar-
macists (which may not include the pro-
vision of public health information and 
services) and the fact that interactions 
with clients at pharmacies are mostly 
with frontline staff some of whom lack 
formal training in health service provi-
sion (PATH, 2004). Second, private 
pharmacy providers are often faced 
with the challenge of balancing opera-
tions as a business establishment and 
performing the role of health service 
providers (Skibiak et al., 2001; PATH, 
2004). 
Given these limitations and the fact 
that private sector pharmacies are the 
preferred sources of EC pills (Morgan, 
2007; Keesbury et al., 2008), effectively 
enhancing the capacity of the providers 
to offer additional RH services to EC 
clients remains a challenge. One strat-
egy which has been found to be effec-
tive is the provision of on-the-job 
training (PATH, 2004). Nonetheless, 
this strategy can, in the long-term, be 
unsustainable because of high rates of 
staff turnover and cost. In 2008, Popula-
tion Council tested the feasibility of 
using a strategy that involved regular 
visits and updates to the providers at 
the facilities as a way of enhancing their 
capacity to offer counselling and refer-
ral for regular FP and other RH services 
to EC users. The study was conducted 
in Nairobi, Kenya, and involved the pro-
vision of information, education and 
communication (IEC) materials as well 
as regular updates on EC use and provi-
sion, including the need to ‘bridge’ 43
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services. This paper presents the 
results of the baseline assessment of the 
provision of EC in the private sector 




The first criterion for selecting the 
pharmacies to include in the study was 
that they already had contact with the 
Population Services International (PSI) 
social marketing programs. This meant 
that they were stocking and selling EC. 
PSI provided a list of the busiest phar-
macies in Nairobi that were staffed by a 
pharmacologist, a pharmacist, or a 
pharmacy assistant. From a total of 98 
pharmacies that satisfied this criterion, 
20 were randomly selected for inclu-
sion in the study. Time and financial 
constraints played a role in the decision 
to base the study on the 20 pharmacies. 
Twelve female research assistants were 
then recruited and trained to act as 
mystery clients (MCs) in need of EC 
pills. These were single women aged 
between 19 and 32 years, in line with 
findings from previous studies which 
show that the main users of EC fall 
within this age group (Shawe et al., 
2001; Olszewski et al., 2007).
The MCs were trained to present 
the providers with two scenarios which 
were developed with the help of a 
group of pharmacists from some of the 
outlets that were not selected for inclu-
sion in the study. The first scenario was 
that of an inexperienced EC client who 
had had unprotected sex one or two 
days prior to the visit date, and was not 
sure if there was a method that she 
could use to avoid getting pregnant. 
The second scenario was that of an 
experienced client who knew the prod-
uct she wanted and went to the phar-
macy to ask for it. The visits to 
pharmacies were arranged such that 
each pharmacy could only be visited by 
at most two different MCs each day to 
avoid saturating the pharmacies with 
visits. The MCs played alternating roles 
such that if the first visitor to a phar-
macy in a particular day was an inexpe-
rienced client, the next would play the 
role of an experienced one. Nonethe-
less, the proportion of visits when the 
MCs presented as inexperienced EC 
users was more than when they pre-
sented as experienced users by the 
ratio of three to one (Table 1) because: 
1) each day all MCs started by present-
ing as inexperienced clients; and 2) not 
all pharmacies were visited six times 
(the maximum number of visits to a 
pharmacy).
The MCs observed the provider’s 
ability to respond to the need for EC as 
an FP method as well as to special 
needs within the broader RH context, 
including counselling and referral for 
regular FP and STI/HIV services. To 
reduce recall bias, the MCs were 
debriefed immediately following their 
pharmacy visits. They responded to a 
short questionnaire on whether: 1) 
there were any IEC materials on EC at 
the pharmacy, 2) they were provided 
with EC pills and any information on the 
method, and 3) the provider talked to 
them about other FP methods as well 
as STIs and HIV. In addition to the ques-
tionnaire, the MCs provided qualitative 
accounts of their experiences at each 
pharmacy, first by narrating their expe-
riences verbatim, then by recording the 
narratives in notebooks provided for 44
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ings from both the quantitative data and 
the qualitative accounts. 
Mystery client method and ethical 
issues 
The mystery client method entails using 
trained people to visit program facilities 
in the assumed role of real clients, and 
then report on their experience by 
completing a survey or through an 
interview (Boyce and Neal, 2006). The 
use of MCs helps to avoid bias in the 
service delivery process that can result 
from directly observing service transac-
tions. In the case of EC provision, direct 
observation is likely to lead to even 
more serious bias as clients usually pre-
fer fast and confidential delivery of serv-
ice. Moreover, since MCs are used to 
assess and improve the quality of serv-
ices, they serve the interests of clients, 
providers and programs by highlighting 
ways in which service provision could 
be enhanced (Boyce and Neal, 2006). 
However, the method has its disadvan-
tages. For instance, service providers 
may consider it deceitful if they find out 
that they are not dealing with real cli-
ents. The MCs face potential physical or 
psychological harm when their real 
intentions are discovered, or when they 
are provided with services they do not 
need (Huntington and Schuler, 1993; 
Boyce and Neal, 2006).
To minimize the possibility of pro-
viders discovering the real intentions of 
the MCs, two-thirds of the training was 
devoted to role plays to ensure that the 
MCs were comfortable with their roles. 
They were also made to understand 
that under no circumstances were they 
to act in a manner that would raise sus-
picion on the part of the providers that 
they were not genuine clients. Further-
more, the MC visits were scheduled 
such that no client visited a pharmacy 
more than once. With respect to the 
potential risk of MCs being offered 
services they did not need, it was 
emphasized during training that they 
were not required to undergo any type 
of medical exam or procedure during 
their visits. The project also provided 
the MCs with money for purchasing EC 
from the pharmacies in the event that 
they were offered the pills. The pur-
chased pills were then surrendered to 
the project during debriefing. 
The project further obtained writ-
ten consent to participate in the study 
from the selected pharmacies. The 
process involved explaining the study 
and its purpose, letting the pharmacists 
know that their facilities would be vis-
ited by MCs, explaining the potential 
risks and benefits of participating in the 
study, as well as emphasizing that par-
ticipation was voluntary and that a facil-
ity could withdraw from the study any 
time. The providers were, however, 
not informed about the identities of the 
MCs or the exact dates when they 
would visit. Written consent was also 
obtained from the MCs on the first day 
of training after they were provided 
with the relevant information about the 
assignment, including the risks and ben-
efits involved. Ethical clearance for the 
study was obtained from the Ethics 
Review Committee of the Kenya Medi-
cal Research Institute (KEMRI).
Results
The MCs made a total of 103 visits to 
the selected pharmacies over three 
days of baseline assessment of EC pro-
vision (Table 1). Only one pharmacy 
was visited twice because, though the 45
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to allow the pharmacy to be included in 
the study, written consent was obtained 
on the second day of the assessment. 
The MCs presented the scenario of 
inexperienced clients in nearly three-
quarters of the visits, and were 
attended to by female service providers 
in more than half of the visits.
Table 1: Percent distribution of mystey client visits to pharmacies by 
various background characteristics
Characteristics Percent Number of visits 
(N)





Scenario presented by mystery client
Experienced client 27 28






Pharmacy assistant 21 22
Could not tell 66 68
Total 100 103
Notes: Percentages may not add up to exactly 100 in some cases 
because of rounding.
The MCs were provided with EC pills 
in about four-fifths of the visits to phar-
macies (Table 2). Purchase statistics fur-
ther show that Postinor-2 and ECEE2 
were the only available brands: the 
former comprised 97% of the pur-
chased products with the cost ranging 
from slightly more than one to two 
United States (US) dollars depending on 
the pharmacy. The main reasons for 
non-provision of EC were that: 1) the 
pharmacists insisted on doctors’ pre-
scriptions before they could dispense 
EC, and 2) the pills were out of stock at 
the time of the visit. This is illustrated 
by the following excerpts from qualita-
tive accounts:
I approached this lady at the 46
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fession, and as I explained my 
situation, that I had sex and 
wanted some help to prevent 
unwanted pregnancy, she told 
me that they don’t sell those 
drugs without a doctor's pre-
scription. So there was no way 
she could help me. (MC No. 
RA06; Pharmacy No. WE23).
The man who attended to me 
didn’t cooperate. After giving my 
story, he told me to go see a 
doctor who would give me a 
prescription. Then I take the 
prescription to him. (MC No. 
RA10; Pharmacy No. WE16)
I went to the chemist and found 
this man standing at the counter. 
I approached him and told him 
that I had unprotected sex last 
night and I have been advised by 
a friend that there are pills I 
could take to prevent concep-
tion. He told me to go and get all 
the information about EC before 
contemplating using the pills. I 
insisted that he tells me about 
the EC pills but he told me that 
they were out of stock because 
he had just sold the last packet. 
(MC No. RA10; Pharmacy No. 
KI77)
The lady attendant seemed to 
know about ECs ... On asking 
for P-2 [Postinor 2], the lady 
responded by saying that they 
had the medication but it got fin-
ished. But they would have them 
by the following day. (MC No. 
RA06; Pharmacy No. MA75) 
Table 2: Percent distribution of mystery client visits by the type of reproductive health 
information/ services offered and by the scenario presented
















Mystery client provided with EC 82 81 ns 82 103
Mystery client offered additional 
information on EC
25 69 ** 57 103
Additional EC information 
provideda
When to use EC (time 
frame) 
57 60 ns 59 59
 How to use EC (dosage) 71 83 ns 81 59
Advantages of using EC 
(what EC does)
29 12 ns 14 59
Side-effects of EC (disad-
vantages)
57 46 ns 47 59
Efficacy (how effective EC 
is)
43 42 ns 42 59
 Other 14 6 ns 7 5947
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tional information on EC in more than 
half of the visits, they received addi-
tional information and/or services on 
other FP services and HIV/AIDS/STIs in 
less than a quarter of the visits (Table 
2). This is also reflected in the propor-
tion of pharmacies that offered these 
additional services: 60% offered addi-
tional information on EC to clients in 
one-half or more of the visits while only 
15% offered additional information 
and/or services on other FP methods 
and HIV/AIDS/STIs for a similar propor-
tion of client visits (Figure 1). 
Additional information on EC given to 
clients mostly entailed how (dosage) 
and when (time frame) to use the 
method, with side-effects and efficacy 
ranking third and fourth respectively 
(Table 2). However, qualitative 
accounts indicate that the content of 
the additional EC information varied 
from provider to provider:
She told me to take the two tab-
lets at once and the other one 
within the first 72 hours. She 
told me that some people sub-
stitute EC for FP but that will 
affect them later in life. Then I 
inquired what these effects are 
and she said that it causes some 
hormonal imbalance and can 
result in irregular periods and a 
time will come when they will 
not work in the body of the user. 
(MC No. RA01; Pharmacy No. 
CE68)
Provider gave/talked about other 
FP methods 
18 21 ns 20 103
Type of other FP service offereda
Given regular FP method 0 6 ns 5 21
Recommended regular FP 80 69 ns 71 21
Referred to clinic/hospital 
for FP 
20 38 ns 33 21
 Other 20 13 ns 14 21
Provider talked about HIV/AIDS 
and other STIs
14 15 ns 15 103
Type of HIV/AIDS/STI service 
offereda
 Recommended condoms 50 64 ns 60 15
 Recommended abstinence 50 27 ns 33 15
 Referred to VCT centre 25 55 ns 47 15
 Referred to clinic/hospital 75 55 ns 60 15
 Other 0 9 ns 7 15
Notes: aQuestions allowed for multiple responses- the percentages do not therefore add up to 
100; EC- emergency contraceptives; FP- family planning; STIs- sexually transmitted infections; 
VCT- voluntary counselling and testing; Chi-square tests significant at **p<0.01; *p<0.05; ns- 
not statistically significant.48
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Less than half One-half or more
Figure 1: Percent distribution of pharmacies by the proportion of client visits during 
which additional reproductive health information/service was provided.
Notes:  EC- emergency contraceptives; FP- family planning; STIs- sexually transmitted  
infections.
As I was packing the pill in my 
bag, I decided to ask him how to 
use it and he said that I should 
take one right then and the 
other after 6 hours or, I could 
take two of them at once. (MC 
No. RA09; Pharmacy No. 
MA75)
The attendant told me to take 
both pills at the same time, 
because to her, they would be 
more effective … When I told 
her that 48 hours had elapsed, 
she was afraid and told me to 
take both pills at once. (MC No. 
RA12; Pharmacy No. CE29)
The woman explained to me 
that it is very effective if used 
within the first twelve hours but 
as I had told her I had sex two 
days ago, she told me that it 
might not be very effective, 
especially if my fertility rate is 
high. She told me for it to be 
effective, I take two immedi-
ately. (MC No. RA05; Pharmacy 
No. KI76)
Qualitative data indicate that most pro-
viders who offered additional informa-
tion on EC mentioned the 72-hour 
window within which the pills are effec-
tive. In addition, whereas some provid-
ers recommended taking one tablet 
twelve hours apart, others recom-
mended a shorter time between doses 
while others told the clients to take the 
two tablets at once. Furthermore, most 
providers who mentioned side-effects 
identified nausea and vomiting as the 
most common ones with some men-
tioning hormonal imbalance, ectopic 
pregnancy, infertility, body resistance, 
and irregular monthly periods as other 
side-effects. In some instances, the pro-49
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inserts in the EC packets for more 
information as illustrated by the follow-
ing accounts: 
She didn’t have much informa-
tion about the side effects when 
I asked her but referred me to 
read the paper inside the packet. 
(MC No. RA01; Pharmacy No. 
CE55)
He told me to take one and the 
other one after 12 hours and 
also to make sure I read and fol-
low the instructions in the leaflet 
as he quickly left to serve 
another client. (MC No. RA09; 
Pharmacy No. CE29)
The attendant at first denied me 
any assistance because I didn’t 
know the type of pill that was 
good for me and my body. Later, 
he accepted to give me the EC 
pills and he advised me to read 
the instructions from the 
attached leaflet. (MC No. RA11; 
Pharmacy No. KI77)
The likelihood of clients being offered 
additional information on EC was signif-
icantly higher when they presented as 
inexperienced rather than as experi-
enced users of EC (Table 2). However, 
there was no significant difference in 
the proportion of MC visits when the 
providers talked about other FP meth-
ods or HIV/AIDS/STIs by the scenario 
presented. Providers who talked about 
other FP methods mostly recom-
mended a regular method while those 
who talked about HIV/AIDS/STIs more 
often recommended condoms or 
referred the clients to a health centre.
Discussion and implications
One of the key experiences of mystery 
clients in the study is the insistence by 
some pharmacists on doctors’ prescrip-
tions before they could dispense EC. 
This is in contrast to the 2005 Ministry 
of Health (MOH)/Department of 
Reproductive Health (DRH) guidelines 
for family planning service provision in 
Kenya. With respect to EC, the guide-
lines stipulate that the pills can be pro-
vided by all trained service providers, 
and in any facility with a qualified pro-
vider (MOH/DRH, 2005). The require-
ment for a prescription from a doctor 
has both time and financial implications 
for potential EC users, especially those 
who need it because they engaged in 
consensual unprotected sex. The time 
required to secure a doctor’s appoint-
ment and for consultation beats the 
logic of EC being used for emergency 
cases while the doctor’s consultation 
fee adds additional cost to the user. This 
could have a double-sided effect on EC 
use: on the one hand, doctors might be 
in a better position to provide adequate 
information to potential clients than 
pharmacists; on the other hand, it could 
limit access by those who genuinely 
need the method but are unable to 
raise the doctor’s fees. 
The second important experience 
of MCs is the variation among providers 
on how and when to use EC pills. Most 
providers were aware of the 72-hour 
window of opportunity during which 
EC pills can help prevent unwanted 
pregnancy after unprotected sex. How-
ever, recent guidelines indicate that EC 
pills can be effective for up to 120 hours 
(International Consortium for Emer-
gency Contraception (ICEC), 2004; 
MOH/DRH, 2005). This discrepancy 50
http://aps.journals.ac.za
African Population Studies Vol  24, 1&2 (2010)could largely be a result of what seems 
to be confusion in the field rather than 
the ignorance of the providers: whereas 
the 120-hour guideline has been around 
for some time, product inserts still indi-
cate 72 hours. The variations in recom-
mended dosage and side-effects among 
providers, however, point to the need 
for provider training and/or updates on 
EC use and provision. This might seem 
to contradict the earlier contention that 
provider training might not be sustaina-
ble in the long term due to the high rate 
of staff turnover at private pharmacies. 
Nonetheless, EC use and provision 
could be included in the curriculum 
used for pre-service training for health 
service providers, including pharma-
cists. A study in Bangladesh, for 
instance, showed that this is an effective 
strategy for encouraging bridging (Hos-
sain, 2008). The finding that the MCs 
were more likely to be offered addi-
tional information on EC than to 
receive additional information on other 
FP methods and HIV/AIDS/STIs under-
scores the need for provider training 
and/or updates on bridging. 
Finally, differences in the likelihood 
of being offered additional information 
on EC by the scenario presented by the 
MCs suggest that interventions should 
not just focus on providers but also on 
clients. Clients need to be sensitized on 
the need to obtain additional informa-
tion on EC and other RH services from 
the providers. However, one of the 
challenges could be how to handle 
experienced clients who feel that they 
know what they need and are for quick 
service. A possible way around this 
could be to include a simple message or 
informational insert in the EC packet to 
inform users about other RH services. 
This, however, requires coordination 
with EC manufacturers; its feasibility is 
therefore subject for further research.
Notes
1. The pharmacy study was imple-
mented by the Population Council 
in collaboration with Population 
Services International (PSI) through 
funding from the William and Flora 
Hewlett Foundation. The Kenya 
Medical Research Institute (KEMRI) 
provided ethical clearance for the 
study. We also acknowledge the 
team of research assistants who 
acted as mystery clients and the 
proprietors of pharmacies who 
provided consent for their outlets 
to be included in the study. The 
views expressed in this paper are, 
however, those of the authors.
2. EC or the ‘morning after’ pills refer 
to methods used to prevent preg-
nancy after unprotected sexual 
intercourse. The pills are effective 
for up to five days (120 hours) after 
unprotected sex, but the sooner 
they are taken, the better they 
work. EC pills prevent pregnancy 
through inhibiting or delaying ovula-
tion, thereby preventing fertilization 
and implantation. The pills are not 
effective once a woman is pregnant 
– they neither interrupt an existing 
pregnancy nor cause abortion.
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